Patrys Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About PAB
Patrys Limited (PAB) is a publicly listed company focused on developing novel antibody technologies for cancer and NETosis-driven inflammatory diseases. Patrys listed on the Australian Stock Exchange (ASX) in 2007 to develop new antibody therapies for the treatment of cancer. In 2016, Patrys secured worldwide license from Yale University for the use of deoxymab antibodies as human therapeutic agents for treatment and management of cancer.
Find out what a historical investment in Patrys Limited would be worth today using our PAB stock calculator.
Sector
Health Care
CEO
-
Industry
Biotechnology
Website
patrys.com
$5M
-1.18
-
$0.00
$0.00
$0.00
$0.01
$0.00
Ready to start your investing journey with Stake?
Open an accountAnnouncements
PAB FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PAB
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PAB
on Stake
Buy PAB from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
